Literature DB >> 19960315

Vesicle traffic to the immunological synapse: a multifunctional process targeted by lymphotropic viruses.

Andrés Alcover1, Maria-Isabel Thoulouze.   

Abstract

The site of contact between T lymphocytes and antigen-presenting cells becomes, upon antigen recognition, an organized junction named the immunological synapse. Various T cell organelles polarize, together with microtubules, toward the antigen-presenting cell. Among them, intracellular vesicular compartments, such as the Golgi apparatus, the recycling endosomal compartment, or cytotoxic granules help to build the immunological synapse and ensure effector functions, such as polarized secretion of cytokines by helper T cells, or exocytosis of lytic granules by cytotoxic T cells. Lymphotropic retroviruses, such as the human immunodeficiency virus type 1, the human T cell leukemia virus type 1, or the Herpesvirus saimiri, can subvert some of the vesicle traffic mechanisms impeding the generation and function of the immunological synapses. This review focuses on the polarization of vesicle traffic, its regulation, and its role in maintaining the structure and function of the immunological synapse. We discuss how some lymphotropic viruses target the vesicle traffic in T lymphocytes, inhibiting the formation of immunological synapses and modulating the response of infected T cells.

Entities:  

Mesh:

Year:  2010        PMID: 19960315     DOI: 10.1007/978-3-642-03858-7_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  9 in total

1.  La(s)t but not least.

Authors:  Bernard Malissen; Didier Marguet
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

2.  A role for novel lipid interactions in the dynamic recruitment of SNX27 to the T-cell immune synapse.

Authors:  María Tello-Lafoz; Rajesh Ghai; Brett Collins; Isabel Mérida
Journal:  Bioarchitecture       Date:  2015-05-21

3.  SNX17 affects T cell activation by regulating TCR and integrin recycling.

Authors:  Douglas G Osborne; Joshua T Piotrowski; Christopher J Dick; Jin-San Zhang; Daniel D Billadeau
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

4.  Intraflagellar transport: a new player at the immune synapse.

Authors:  Francesca Finetti; Silvia Rossi Paccani; Joel Rosenbaum; Cosima T Baldari
Journal:  Trends Immunol       Date:  2011-04       Impact factor: 16.687

Review 5.  Immune synapse: conductor of orchestrated organelle movement.

Authors:  Noa Beatriz Martín-Cófreces; Francesc Baixauli; Francisco Sánchez-Madrid
Journal:  Trends Cell Biol       Date:  2013-10-24       Impact factor: 20.808

6.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.

Authors:  María Mittelbrunn; Cristina Gutiérrez-Vázquez; Carolina Villarroya-Beltri; Susana González; Fátima Sánchez-Cabo; Manuel Ángel González; Antonio Bernad; Francisco Sánchez-Madrid
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

7.  Regulated vesicle fusion generates signaling nanoterritories that control T cell activation at the immunological synapse.

Authors:  Helena Soares; Ricardo Henriques; Martin Sachse; Leandro Ventimiglia; Miguel A Alonso; Christophe Zimmer; Maria-Isabel Thoulouze; Andrés Alcover
Journal:  J Exp Med       Date:  2013-10-07       Impact factor: 14.307

Review 8.  Interplay Between SNX27 and DAG Metabolism in the Control of Trafficking and Signaling at the IS.

Authors:  Natalia González-Mancha; Isabel Mérida
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

9.  Shigella impairs human T lymphocyte responsiveness by hijacking actin cytoskeleton dynamics and T cell receptor vesicular trafficking.

Authors:  Fatoumata Samassa; Mariana L Ferrari; Julien Husson; Anastassia Mikhailova; Ziv Porat; Florence Sidaner; Katja Brunner; Teck-Hui Teo; Elisabetta Frigimelica; Jean-Yves Tinevez; Philippe J Sansonetti; Maria-Isabel Thoulouze; Armelle Phalipon
Journal:  Cell Microbiol       Date:  2020-03-01       Impact factor: 3.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.